Author:
Boehling Peter,Jacevic Dalibor,Detobel Frederik,Holman James,Wareham Laura,Metzger Matthew,Khinast Johannes G.
Abstract
AbstractContinuous manufacturing is increasingly used in the pharmaceutical industry, as it promises to deliver better product quality while simultaneously increasing production flexibility. GEA developed a semi-continuous tablet coater which can be integrated into a continuous tableting line, accelerating the switch from traditional batch production to the continuous mode of operation. The latter offers certain advantages over batch production, e.g., operational flexibility, increased process/product quality, and decreased cost. However, process understanding is the key element for process control. In this regard, computational tools can improve the fundamental understanding and process performance, especially those related to new processes, such as continuous tablet coating where process mechanics remain unclear. The discrete element method (DEM) and computational fluid dynamics (CFD) are two methods that allow transition from empirical process design to a mechanistic understanding of the individual process units. The developed coupling model allows to track the heat, mass, and momentum exchange between the tablet and fluid phase. The goal of this work was to develop and validate a high-fidelity CFD-DEM simulation model of the tablet coating process in the GEA ConsiGma® coater. After the model development, simulation results for the tablet movement, coating quality, and heat and mass transfer during the coating process were validated and compared to the experimental outcomes. The experimental and simulation results agreed well on all accounts measured, indicating that the model can be used in further studies to investigate the operating space of the continuous tablet coating process.
Funder
Graz University of Technology
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference52 articles.
1. U.S. Department of Health and Human Services Food and Drug Administration, February C for DE and R (CDER). Quality Considerations for Continuous Manufacturing Guidance for Industry Quality Considerations for Continuous Manufacturing Guidance for Industry(draft) [Internet]. 2019. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/quality-considerations-continuous-manufacturing
2. Chatterjee S. FDA Perspective on Continuous Manufacturing. In: IFPAC Annual Meeting [Internet]. Baltimore; 2012. Available from: https://www.fda.gov/files/aboutfda/published/FDA-Perspective-on-Continuous-Manufacturing%2D%2DSharmista-Chatterjee%2D%2DPh.D.%2D%2DJanuary-22%2D%2D2012%2D%2DIFPAC-Annual-Meeting.pdf.
3. Sacher S, Wahl P, Weißensteiner M, Wolfgang M. Shedding light on coatings: real-time monitoring of coating quality at industrial scale. Int J Pharm. 2019;566:57–66.
4. Rehrl J, Karttunen A, Nicolaï N, Hörmann T, Horn M. Control of three different continuous pharmaceutical manufacturing processes : use of soft sensors. Int J Pharm. 2018;543:60–72.
5. Silva AF, Vercruysse J, Vervaet C, Remon JP, De Beer T, Sarraguça MC. In-depth evaluation of data collected during a continuous pharmaceutical manufacturing process: a multivariate statistical process monitoring approach. J Pharm Sci. 2019;108:439–50.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献